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Background: The role of neointimal angiogenesis in human in-stent restenosis has not been studied.
Methods: We analyzed 65 post-mortem stented arteries from 33 patients with duration > 3 months. There were 28 males and 5 females; cause 
of death was determined incidental to the coronary findings in every case. There were 34 drug eluting stents (DES) and 31 bare metal stents 
(BMS). Stented segments were embedded in paraffin and stained immunohistochemically for CD68 (macrophages), and endothelial markers 
PECAM-1 (CD31) and endoglin (CD105). Computerized morphometry was performed to quantitate neovessel density for PECAM-1 and CD105, as 
well as plaque and neointimal area. In-stent restenosis was defined as luminal narrowing > 75% cross-section of the stented area. Macrophage 
inflammation was assessed semi-quantitatively in the underlying plaque and the neointima; underlying plaque morphology was classified as fibrous 
or atheromatous.
Results: Neovessels were present in the neointima of 57 stented segments (88%). Mean neovessel density was greater in restenotic vs. non-
restenotic neointimae as assessed by PECAM-1 (7.5 ± 5.7 vs. 4.0 ± 4.1 / mm2, p=.005) and CD105 (9.8 ± 1.2 vs. 5.5 ± 4.7 / mm2, p=.005). 
Neointimal area correlated positively with density of neointimal vessels (p=.01, r2 = 0.09 for PECAM-1, p=.04, r2 = .06 for CD105), but not type 
of stent (BMS or DES), underlying plaque type, or underlying plaque macrophage score. Neovessel density correlated with neointimal macrophage 
density as assessed by PECAM-1 staining (p= .06) and CD105 staining (p= .004).
Conclusions: We conclude that in-stent restenosis is associated with neointimal angiogenesis which is accompanied by macrophage 
inflammation. The relevance of these findings to treatment and prevention of in-stent restenosis needs to be further explored.
